X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
anemia (5) 5
index medicus (5) 5
sickle cell (5) 5
hematology (4) 4
hydroxyurea (4) 4
antimicrobial peptide (3) 3
cell death (3) 3
chagas' disease (3) 3
diseases of the blood and blood-forming organs (3) 3
dna damage (3) 3
flow cytometry (3) 3
haplotypes (3) 3
inflammation (3) 3
necrosis (3) 3
original article (3) 3
peptides (3) 3
sickle cell anemia (3) 3
trypanosoma cruzi (3) 3
trypanosoma-cruzi (3) 3
tumor necrosis factor-alpha (3) 3
venom (3) 3
adult (2) 2
amastigotes (2) 2
anemia, sickle cell (2) 2
anemia, sickle cell - genetics (2) 2
animals (2) 2
benznidazole (2) 2
cathelicidin (2) 2
chronic infection (2) 2
female (2) 2
genetic aspects (2) 2
health aspects (2) 2
humans (2) 2
interiorization (2) 2
male (2) 2
medicine, research & experimental (2) 2
membranes (2) 2
middle aged (2) 2
parasites (2) 2
protozoa (2) 2
scanning electron microscopy (2) 2
toxicology (2) 2
trypanosoma cruzi - drug effects (2) 2
vector-borne diseases (2) 2
venom gland (2) 2
aged (1) 1
amplification (1) 1
analysis (1) 1
anemia falciforme (1) 1
anemia, sickle cell - blood (1) 1
anemia, sickle cell - drug therapy (1) 1
anemia, sickle cell - pathology (1) 1
ant venom (1) 1
antibiotics (1) 1
antifungal activity (1) 1
antiinfectives and antibacterials (1) 1
antimicrobial cationic peptides - isolation & purification (1) 1
antimicrobial cationic peptides - pharmacology (1) 1
antimicrobial peptides (1) 1
antiparasitic agents - pharmacology (1) 1
antitrypanosomal agents (1) 1
ants (1) 1
apoptosis (1) 1
batroxicidin (1) 1
beta haplotypes (1) 1
biochemical markers (1) 1
biochemistry & molecular biology (1) 1
biotechnology & applied microbiology (1) 1
bothrops (1) 1
brazil (1) 1
care and treatment (1) 1
cathelicidin-like peptide (1) 1
cathelicidins (1) 1
cell death - drug effects (1) 1
cell membranes (1) 1
chagas disease (1) 1
chagas-disease (1) 1
comet assay (1) 1
cross-sectional studies (1) 1
crotalicidin (1) 1
crotalid venoms - chemistry (1) 1
cytokines (1) 1
cytotoxicity (1) 1
dinoponera quadriceps (1) 1
dinoponeratoxins (1) 1
discovery (1) 1
disease patients (1) 1
dna (1) 1
dose-response relationship, drug (1) 1
drug resistance in microorganisms (1) 1
drugs (1) 1
fetal-hemoglobin (1) 1
follow-up (1) 1
fungicides (1) 1
gene-cluster haplotypes (1) 1
genes (1) 1
genetic (1) 1
genetic polymorphisms (1) 1
genetic research (1) 1
genetics (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Mutation Research. Genetic Toxicology and Environmental Mutagenesis, ISSN 1383-5718, 12/2012, Volume 749, Issue 1-2, p. 48
  Hydroxyurea (HU) is the primary pharmacologic agent for preventing the complications and improving the quality of life of sickle cell anemia (SCA) patients.... 
Polymerase chain reaction | Leucocytes | Sickle cell anemia | Risk assessment | Leukemia | DNA damage | Quality of life
Journal Article
Revista Brasileira de Hematologia e Hemoterapia, ISSN 1806-0870, 04/2014, Volume 36, Issue 2, pp. 121 - 125
Background: Sickle cell anemia is a chronic inflammatory disease characterized by an increased production of proinflammatory cytokines including tumor necrosis... 
MEDICINE, RESEARCH & EXPERIMENTAL | HEMATOLOGY
Journal Article
Biological Chemistry, ISSN 1431-6730, 01/2018, Volume 399, Issue 2, pp. 187 - 196
Journal Article
Revista Brasileira de Hematologia e Hemoterapia, ISSN 1806-0870, 2012, Volume 34, Issue 4, pp. 265 - 269
BACKGROUND: Sickle cell disease is a hemoglobinopathy characterized by hemolytic anemia, increased susceptibility to infections and recurrent vaso-occlusive... 
MEDICINE, RESEARCH & EXPERIMENTAL | HEMATOLOGY
Journal Article
Mutation Research - Genetic Toxicology and Environmental Mutagenesis, ISSN 1383-5718, 12/2012, Volume 749, Issue 1-2, pp. 48 - 52
► The mutagenicity in sickle cell anemia is associated with genetic polymorphisms. ► Damage index to the Bantu haplotype was greater than the Benin haplotype.... 
Hydroxyurea | HBBS gene haplotypes | Sickle cell anemia | Comet assay | Genotoxicity | HBB | S gene haplotypes | DISEASE PATIENTS | FOLLOW-UP | BETA(S) HAPLOTYPES | GENE-CLUSTER HAPLOTYPES | BRAZIL | MUTAGENICITY | AMPLIFICATION | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | FETAL-HEMOGLOBIN | GENETICS & HEREDITY | TOXICOLOGY | LYMPHOCYTES | Care and treatment | DNA damage | Genes | DNA | Genetic research | Genetic aspects | Index Medicus
Journal Article
Revista Brasileira de Hematologia e Hemoterapia, ISSN 1516-8484, 03/2014, Volume 36, Issue 2, pp. 121 - 125
Sickle cell anemia is a chronic inflammatory disease characterized by an increased production of proinflammatory cytokines including tumor necrosis... 
Haplotypes | Hydroxyurea | Tumor necrosis factor-alpha | Anemia, sickle cell | Inflammation
Journal Article
Revista brasileira de hematologia e hemoterapia, ISSN 1516-8484, 03/2014, Volume 36, Issue 2, pp. 121 - 125
Journal Article
Revista Brasileira de Hematologia e Hemoterapia, ISSN 1516-8484, 03/2014, Volume 36, Issue 2, pp. 121 - 125
Sickle cell anemia is a chronic inflammatory disease characterized by an increased production of proinflammatory cytokines including tumor necrosis... 
Haplotypes | Tumor necrosis factor-alpha | Anemia | sickle cell | Hydroxyurea | Inflammation
Journal Article
Revista Brasileira de Hematologia e Hemoterapia, ISSN 1516-8484, 2014, Volume 36, Issue 2, pp. 121 - 125
Sickle cell anemia is a chronic inflammatory disease characterized by an increased production of proinflammatory cytokines including tumor necrosis... 
Haplotypes | Hydroxyurea | Tumor necrosis factor-alpha | Inflammation | Anemia | Sickle cell | sickle cell | Original article
Journal Article
Revista Brasileira de Hematologia e Hemoterapia, ISSN 1516-8484, 2012, Volume 34, Issue 4, pp. 265 - 269
Sickle cell disease is a hemoglobinopathy characterized by hemolytic anemia, increased susceptibility to infections and recurrent vaso-occlusive crises that... 
Lactate dehydrogenase | Nitrite | Anemia | Malonaldehyde | Sickle cell | Anemia, sickle cell | Original
Journal Article
Mutation research, ISSN 0027-5107, 12/2012, Volume 749, Issue 1-2, p. 48
Hydroxyurea (HU) is the primary pharmacologic agent for preventing the complications and improving the quality of life of sickle cell anemia (SCA) patients.... 
Mutagens - toxicity | Humans | Middle Aged | Hemoglobins - genetics | Male | Anemia, Sickle Cell - drug therapy | Hemoglobin, Sickle - genetics | Hydroxyurea - adverse effects | Adult | Female | Aged | DNA Damage | Leukocytes - chemistry | Anemia, Sickle Cell - genetics
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.